Associated Papers
Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.
Georgakis MK et al.
Genome Medicine, 2025
40119478 (PubMed )
Supplement: 13073_2025_1456_MOESM2_ESM.xlsx › Table_S2
Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.
Georgakis MK et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
37645892 (PubMed )
Supplement: media-2.xlsx › SupplTable2
Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism.
den Hollander LS et al.
Biochemical Pharmacology, 2023
Select a paper to view details